"Arthritis Research Canada is the largest clinical arthritis research institution in North America with four centres located across Canada and affiliated with five major Canadian universities. The organization conducts arthritis research to find answers and save lives."

During the past decade, Arthritis Research Centre of Canada conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arthritis Research Centre of Canada" #1 sponsor was "Amgen" with 2 trials, followed by "University of British Columbia" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Targeted Genetics Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis Research Centre of Canada" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Simon Fraser University" with 2 trials as a collaborator, "Arthritis Research Centre of Canada" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "University of Calgary" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis Research Centre of Canada" are "Rheumatoid Arthritis" (4 trials), "Psoriatic Arthritis" (3 trials), "Ankylosing Spondylitis" (1 trials), "Knee Osteoarthritis" (1 trials) and "Lupus Erythematosus, Systemic" (1 trials). Many other conditions were trialed in "Arthritis Research Centre of Canada" in a lesser frequency.

Most popular intervention types in "Arthritis Research Centre of Canada" are "Drug" (4 trials), "Behavioral" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials), "Methotrexate" (2 trials) and "Employment and Arthritis: Making it Work" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis Research Centre of Canada" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Arthritis Research Centre of Canada". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Arthritis Research Centre of Canada, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis Research Centre of Canada, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".